drugset / Trial / NCT00830856

Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

NCT00830856

RandomizedParallel-groupSingle-blindTreatment

Summary

Cryptococcal Meningitis continues to be one of the most devastating AIDS defining illness in sub-Saharan Africa. Despite the availability of azoles such as fluconazole for treatment, mortality remains high with some studies showing 100% mortality. The investigators designed a study to determine if timing of the initiation of antiretroviral therapy (ART) in patients with cryptococcal meningitis and HIV would improve survival. The investigators hypothesis was that early initiation of ART result in improved mortality for patients with HIV and cryptococcal meningitis.

Timeline

Start
2006-10
Primary completion
2008-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamivudine Other / unclassified
Subject Nevirapine Small molecule
Subject Stavudine Other / unclassified
Background Fluconazole Small molecule 800 mg Oral